Stocks and Investing Stocks and Investing
Wed, April 10, 2024
Tue, April 9, 2024

Joseph Stringer Reiterated (APLS) at Strong Buy and Held Target at $85 on, Apr 9th, 2024


Published on 2024-10-28 10:12:53 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Reiterated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $85 on, Apr 9th, 2024.

Joseph has made no other calls on APLS in the last 4 months.



There are 12 other peers that have a rating on APLS. Out of the 12 peers that are also analyzing APLS, 3 agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Graig Suvannavejh of "Mizuho" Maintained at Hold and Held Target at $60 on, Wednesday, March 27th, 2024
  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Wednesday, February 28th, 2024
  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $54 on, Thursday, December 14th, 2023


These are the ratings of the 9 analyists that currently disagree with Joseph


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $79 on, Wednesday, March 6th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $89 on, Monday, March 4th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $92 on, Wednesday, February 28th, 2024
  • Colleen Kusy of "Baird" Reiterated at Buy and Held Target at $81 on, Tuesday, February 6th, 2024
  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $80 on, Monday, February 5th, 2024
  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $79 on, Tuesday, January 30th, 2024
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $106 on, Thursday, January 11th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $67 on, Friday, December 15th, 2023

Contributing Sources